Sunglow Pharmaceuticalss Private Limited, a active private limited company, was established on 18 January 2010 in Pondicherry, Pondicherry, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232PY2010PTC002407. Registered under ROC Roc Pondicherry. it is unlisted. It has an authorized capital of ₹6.75 Cr and a paid-up capital of ₹6.12 Cr.
It upholds a compliant status. Employing 50 professional, Its leadership includes Veerabadran Rajasekaran (Director), Kamaraj (Director). Past directors included Sivasankaran Paramasivam, Jayasree Rajasekhar, Paramasivan Sivarajakumar. It holds ₹1.00 Cr open charges and ₹5.19 Cr settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.29-38, Opposite To Co-Op Milk Dairy (Ponlait) Kurumbapet, Pondicherry, Pondicherry, 605009.
U24232PY2010PTC002407
002407
18 January 2010
₹6.75 Cr
₹6.12 Cr
Roc Pondicherry
Unlisted
Active
Explore comprehensive insights into Sunglow Pharmaceuticalss Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veerabadran Rajasekaran | Director | 09 Sep 2013 | Current |
| Kamaraj | Director | 28 May 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Oct 2013 | Past |
| Pramod Abcsdd | Additional Director | 18 Feb 2011 | Past |
| Pramod Abcsdd | Director | 31 Mar 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Company Secretary | 31 Jan 2020 | Past |
| Pramod Abcsdd | Director | 18 Feb 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sunglow Pharmaceuticalss Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Sunglow Pharmaceuticalss had a promoter holding of 84.44% and a public holding of 15.57%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹51,860,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2017 | Axis Bank Limited | ₹1.00 Cr | Open |
| 30 Jul 2020 | Axis Bank Limited | ₹6.00 M | Satisfied |
| 28 Nov 2013 | Hdfc Bank Limited | ₹3.34 Cr | Satisfied |
| 21 Mar 2011 | Uco Bank | ₹1.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Sunglow Pharmaceuticalss has a workforce of 50 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sunglow Pharmaceuticalss, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunglow Pharmaceuticalss's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited of Rs. 1.00 Cr registered on 14 Feb 2017 with Charge ID 100096074 was modified on 03 Jul 2025. was recorded as a recent event.
Sunglow Pharmaceuticalss Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was recorded as a recent event.
Sunglow Pharmaceuticalss Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pondicherry. was recorded as a recent event.
The activity A charge registered on 30 Jul 2020 via Charge ID 100360502 with Axis Bank Limited was fully satisfied on 17 Dec 2021. was completed.
A charge with Axis Bank Limited amounted to Rs. 0.60 Cr with Charge ID 100360502 was registered on 30 Jul 2020. was recorded as a recent event.
The activity A charge registered on 28 Nov 2013 via Charge ID 10464827 with Hdfc Bank Limited was fully satisfied on 15 Apr 2017. was completed.
The CIN of Sunglow Pharmaceuticalss Private Limited is U24232PY2010PTC002407.
Sunglow Pharmaceuticalss Private Limited is headquartered at Plot No.29-38, Opposite To Co-Op Milk Dairy (Ponlait) Kurumbapet, Pondicherry, Pondicherry, 605009.
Sunglow Pharmaceuticalss Private Limited was incorporated on 18 January 2010.
The current directors of Sunglow Pharmaceuticalss Private Limited are
The primary industry of Sunglow Pharmaceuticalss Private Limited is Manufacturing.
Sunglow Pharmaceuticalss Private Limited is unlisted.
The authorized capital of Sunglow Pharmaceuticalss Private Limited is ₹6.75 Cr, and the paid-up capital is ₹6.12 Cr.
The compliance status of Sunglow Pharmaceuticalss Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX